Celladon Corporation
Latest round
- Series A
Last raised
- May 2012
Total raised
- $47M
Investors
- 11
About Celladon Corporation
Celladon Corporation is a biotechnology company focused on developing innovative treatments for cardiovascular diseases through gene therapy and regenerative medicine.Celladon Corporation, founded in 2000 in the US, is dedicated to developing advanced therapies for cardiovascular conditions. The company has undergone strategic pivots in its business operations, focusing on gene therapy.5 million shares at USD 8 per share on NASDAQ under the ticker 'CLDN'.Celladon specializes in developing innovative biopharmaceutical products targeting cardiovascular diseases. Their primary focus includes gene therapy solutions aimed at improving heart function and addressing heart failure.47 mn. The company generates revenue through the development and commercialization of its biopharmaceutical products, involving significant investments in research and clinical trials. The company is targeting expansion into European and Asian markets by 2025, with a focus on enhancing its global footprint. The recent growth strategy will include investments in clinical trials to validate and bring their innovative therapies to market.
Who invested in Celladon Corporation
11 investors across 4 rounds
See all investors in Celladon Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Celladon Corporation
Who invested in Celladon Corporation?
Celladon Corporation has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Celladon Corporation raised?
Celladon Corporation has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Celladon Corporation last raise money?
Celladon Corporation's most recent round on record is a Series A, in May 2012.
What does Celladon Corporation do?
Celladon Corporation is a biotechnology company focused on developing innovative treatments for cardiovascular diseases through gene therapy and regenerative medicine.
Where is Celladon Corporation headquartered?
Celladon Corporation is headquartered in US.
Which VCs invest in companies like Celladon Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Celladon Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Celladon Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.